| Bioactivity | AZD8154 is a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease. | ||||||||||||
| Name | AZD8154 | ||||||||||||
| CAS | 2215022-45-8 | ||||||||||||
| Formula | C27H29N5O4S2 | ||||||||||||
| Molar Mass | 551.68 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Sadiq MW, et al. Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease. Br J Clin Pharmacol. 2021 Jun 28. |